Dengue Non-structural Protein 5 Polymerase Complexes With Promyelocytic Leukemia Protein (PML) Isoforms III and IV to Disrupt PML-Nuclear Bodies in Infected Cells. [PDF]
Giovannoni F +5 more
europepmc +1 more source
Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. [PDF]
Piazzetta GL +11 more
europepmc +1 more source
Successful Outcome of Acute Promyelocytic Leukemia Complicated by Bone Marrow Necrosis and Posterior Reversible Encephalopathy Syndrome, During Treatment With an All-Trans Retinoic Acid Plus Arsenic Trioxide-Based Regimen. [PDF]
Venou TM +5 more
europepmc +1 more source
Promyelocytic Leukemia Protein Is an Essential Regulator of Stem Cell Pluripotency and Somatic Cell Reprogramming. [PDF]
Hadjimichael C +7 more
europepmc +1 more source
Integrated Proteomic and Metabolomic Profiling in Acute Promyelocytic Leukemia: Current Status and Perspectives. [PDF]
Liu T, Qu M, Wang N, Xing X.
europepmc +1 more source
The autophagy switch: A critical determinant of arsenic-induced carcinogenesis and cancer therapy. [PDF]
Zeinvand-Lorestani M +2 more
europepmc +1 more source
PML::RARA-negative APL-mimicking AML with a novel KMT2C::CREB3L2 fusion and RARA/RXRA-mediated sensitivity to all-trans retinoic acid. [PDF]
Ma L, Wu M.
europepmc +1 more source
A relapsed/refractory acute promyelocytic leukemia achieving complete response after chemotherapy with venetoclax. [PDF]
Zhang X, Hao S, Hu C, Qu R.
europepmc +1 more source
The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations. [PDF]
Hassani MA +8 more
europepmc +1 more source

